Ranolazine 100mg 100mg | Purity Not Available
Adooq Bioscience
Ranolazine is a partial fatty acid oxidation inhibitor, shifts ATP production from fatty acid to more oxygen-efficient carbohydrate oxidation.
More Information Supplier PageRanolazine is a partial fatty acid oxidation inhibitor, shifts ATP production from fatty acid to more oxygen-efficient carbohydrate oxidation.
More Information Supplier PageRamelteon is a melatonin receptor agonist with both high affinity for melatonin MT1 (IC50 =28.5 ?? 8.55 pM)and MT2 (20.1 ?? 9.25 pM)receptors and selectivity over the MT3 receptor.
More Information Supplier PageRamelteon is a melatonin receptor agonist with both high affinity for melatonin MT1 (IC50 =28.5 ?? 8.55 pM)and MT2 (20.1 ?? 9.25 pM)receptors and selectivity over the MT3 receptor.
More Information Supplier PageRamelteon is a melatonin receptor agonist with both high affinity for melatonin MT1 (IC50 =28.5 ?? 8.55 pM)and MT2 (20.1 ?? 9.25 pM)receptors and selectivity over the MT3 receptor.
More Information Supplier PageRamelteon is a melatonin receptor agonist with both high affinity for melatonin MT1 (IC50 =28.5 ?? 8.55 pM)and MT2 (20.1 ?? 9.25 pM)receptors and selectivity over the MT3 receptor.
More Information Supplier PageRamelteon is a melatonin receptor agonist with both high affinity for melatonin MT1 (IC50 =28.5 ?? 8.55 pM)and MT2 (20.1 ?? 9.25 pM)receptors and selectivity over the MT3 receptor.
More Information Supplier PageRaltitrexed (Tomudex) is an inhibitor of thymidylate synthase and also is one of the strongest antimetabolites in use.
More Information Supplier PageRacecadotril is a potent enkephalinase inhibitor which exhibits selective antisecretory activity.
More Information Supplier PageR935788 (Fostamatinib disodium) is a potent orally available inhibitor of Syk that inhibits tumor growth in the E??- TCL1 transgenic mouse model of CLL by blocking antigen-dependent B-cell receptor signaling.
More Information Supplier PageR935788 (Fostamatinib disodium) is a potent orally available inhibitor of Syk that inhibits tumor growth in the E??- TCL1 transgenic mouse model of CLL by blocking antigen-dependent B-cell receptor signaling.
More Information Supplier Page